Anna embarked on her scientific journey at IDIBGI (Spain), where she studied cardiovascular disorders. She later advanced her career at the Center for Neurogenomics and Cognitive Research in Amsterdam, focusing on Alzheimer’s Disease pathophysiology. Following this, Anna pursued her PhD. at VHIR (Spain) where she also secured a postdoctoral position. During her tenure at VHIR, Anna became actively engaged in both preclinical and clinical research on Alzheimer’s Disease and neurovascular disorders. She also played a key role in project management for various clinical studies and pharmaceutical collaborations.

Her research findings have been published in multiple peer-reviewed journals and showcased at international conferences.